Track topics on Twitter Track topics that are important to you
Today, Cigna Ventures (CV), the corporate venture fund of global health service company Cigna, announced that it’s leading a $23M Series D round of funding in GNS Healthcare (GNS), a highly specialized AI company that turns millions of data streams into personalized insights that precisely match the appropriate clinical care/treatment intervention to the right patient at ... Read More
Original Article: Cigna Leads $23M Series D in Specialized AI Company, GNS HealthcareNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...